FZD3 and acute myeloid leukemia: miR-155 and miR-192 inhibit Fzd3/Wnt/β-catenin signaling in acute myeloid leukemia (AML) and decrease transformation, proliferation, and differentiation of AML progenitor cells (Zhang et al., 2017).